Evaxion A/S ADR Company Profile
NASDAQ: EVAXHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
3.05-0.09 (-2.87%)
At close: Oct 8, 4:00 PM ET · Delayed 15 min
Evaxion A/S at a glance
Evaxion A/S ADR (NASDAQ: EVAX) is a Biotechnology: Biological Products (No Diagnostic Substances) company in the Health Care sector. The company's shares have traded publicly since 2021. At a market capitalization of $27.5 million, it is considered a small-cap company.
Its SEC Central Index Key (CIK) is 0001828253, which identifies the company's filings on EDGAR.
Summary generated from market data by MetaCap's automated system. Methodology
Company information
- Legal name
- Evaxion A/S ADR
- Ticker
- NASDAQ: EVAX
- Sector
- Health Care
- Industry
- Biotechnology: Biological Products (No Diagnostic Substances)
- Headquarters
- Denmark
- IPO year
- 2021
- Market cap
- $27.52M
- SEC CIK
- 0001828253
Companies similar to Evaxion A/S
| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| QNCXQuince Therapeutics Inc. | 29.36 | +9.88% | $29.86M | vs EVAX |
| ATYRaTyr Pharma Inc. | 0.2553 | -8.26% | $25.04M | vs EVAX |
| ALGSAligos Therapeutics Inc. | 5.31 | -0.19% | $33.16M | vs EVAX |
| SCLXScilex Holding Company | 2.96 | -15.19% | $20.82M | vs EVAX |
| GNTAGenenta Science S.p.A. ADR | 0.7101 | -5.95% | $34.24M | vs EVAX |
| CVMCel-Sci Corporation | 1.95 | -8.45% | $34.30M | vs EVAX |
| JSPRJasper Therapeutics Inc. | 0.56 | -1.70% | $18.63M | vs EVAX |
| ELUTElutia Inc. Class A | 0.8273 | +0.88% | $36.64M | vs EVAX |